Sustained Improvement in Administration of the Hepatitis B Vaccine Birth Dose

A Quality Improvement Initiative

Sheri L. Nemerofsky, Bolanle Akingboye, Claudia Ferguson, Dawn Africa

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The New York State Department of Health recommends the administration of the hepatitis B vaccine birth dose within 12 hours of life (HOL) for all full-term babies irrespective of maternal hepatitis B status. The primary and secondary aims of the project were to improve the timeliness of vaccine administration and increase the total number of infants vaccinated prior to discharge. Multiple Plan-Do-Study-Act cycles were performed. Statistical process charts of percentages of vaccination within 12 HOL and prior to discharge were constructed with 3-σ (data within 3 standard deviations from a mean) control limits. These control limits were adjusted after achieving significant improvements in performance over time. Administration within 12 HOL improved from 13% to ≥65% within 6 months, and has been sustained for >1 year. Vaccine administration prior to discharge increased from 94% to 98%. Quality improvement methods can rapidly improve adherence to newborn vaccine recommendations and these effects are sustainable.

Original languageEnglish (US)
Pages (from-to)313-320
Number of pages8
JournalAmerican Journal of Medical Quality
Volume33
Issue number3
DOIs
StatePublished - May 1 2018

Fingerprint

Hepatitis B Vaccines
Quality Improvement
Vaccines
Parturition
Hepatitis B
Vaccination
Mothers
Newborn Infant
Health

Keywords

  • hepatitis B vaccine
  • newborn
  • quality improvement
  • vaccine

ASJC Scopus subject areas

  • Health Policy

Cite this

Sustained Improvement in Administration of the Hepatitis B Vaccine Birth Dose : A Quality Improvement Initiative. / Nemerofsky, Sheri L.; Akingboye, Bolanle; Ferguson, Claudia; Africa, Dawn.

In: American Journal of Medical Quality, Vol. 33, No. 3, 01.05.2018, p. 313-320.

Research output: Contribution to journalArticle

@article{efa2a46f144d4912a39352be29f82548,
title = "Sustained Improvement in Administration of the Hepatitis B Vaccine Birth Dose: A Quality Improvement Initiative",
abstract = "The New York State Department of Health recommends the administration of the hepatitis B vaccine birth dose within 12 hours of life (HOL) for all full-term babies irrespective of maternal hepatitis B status. The primary and secondary aims of the project were to improve the timeliness of vaccine administration and increase the total number of infants vaccinated prior to discharge. Multiple Plan-Do-Study-Act cycles were performed. Statistical process charts of percentages of vaccination within 12 HOL and prior to discharge were constructed with 3-σ (data within 3 standard deviations from a mean) control limits. These control limits were adjusted after achieving significant improvements in performance over time. Administration within 12 HOL improved from 13{\%} to ≥65{\%} within 6 months, and has been sustained for >1 year. Vaccine administration prior to discharge increased from 94{\%} to 98{\%}. Quality improvement methods can rapidly improve adherence to newborn vaccine recommendations and these effects are sustainable.",
keywords = "hepatitis B vaccine, newborn, quality improvement, vaccine",
author = "Nemerofsky, {Sheri L.} and Bolanle Akingboye and Claudia Ferguson and Dawn Africa",
year = "2018",
month = "5",
day = "1",
doi = "10.1177/1062860617732635",
language = "English (US)",
volume = "33",
pages = "313--320",
journal = "American Journal of Medical Quality",
issn = "1062-8606",
publisher = "SAGE Publications Inc.",
number = "3",

}

TY - JOUR

T1 - Sustained Improvement in Administration of the Hepatitis B Vaccine Birth Dose

T2 - A Quality Improvement Initiative

AU - Nemerofsky, Sheri L.

AU - Akingboye, Bolanle

AU - Ferguson, Claudia

AU - Africa, Dawn

PY - 2018/5/1

Y1 - 2018/5/1

N2 - The New York State Department of Health recommends the administration of the hepatitis B vaccine birth dose within 12 hours of life (HOL) for all full-term babies irrespective of maternal hepatitis B status. The primary and secondary aims of the project were to improve the timeliness of vaccine administration and increase the total number of infants vaccinated prior to discharge. Multiple Plan-Do-Study-Act cycles were performed. Statistical process charts of percentages of vaccination within 12 HOL and prior to discharge were constructed with 3-σ (data within 3 standard deviations from a mean) control limits. These control limits were adjusted after achieving significant improvements in performance over time. Administration within 12 HOL improved from 13% to ≥65% within 6 months, and has been sustained for >1 year. Vaccine administration prior to discharge increased from 94% to 98%. Quality improvement methods can rapidly improve adherence to newborn vaccine recommendations and these effects are sustainable.

AB - The New York State Department of Health recommends the administration of the hepatitis B vaccine birth dose within 12 hours of life (HOL) for all full-term babies irrespective of maternal hepatitis B status. The primary and secondary aims of the project were to improve the timeliness of vaccine administration and increase the total number of infants vaccinated prior to discharge. Multiple Plan-Do-Study-Act cycles were performed. Statistical process charts of percentages of vaccination within 12 HOL and prior to discharge were constructed with 3-σ (data within 3 standard deviations from a mean) control limits. These control limits were adjusted after achieving significant improvements in performance over time. Administration within 12 HOL improved from 13% to ≥65% within 6 months, and has been sustained for >1 year. Vaccine administration prior to discharge increased from 94% to 98%. Quality improvement methods can rapidly improve adherence to newborn vaccine recommendations and these effects are sustainable.

KW - hepatitis B vaccine

KW - newborn

KW - quality improvement

KW - vaccine

UR - http://www.scopus.com/inward/record.url?scp=85047081161&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047081161&partnerID=8YFLogxK

U2 - 10.1177/1062860617732635

DO - 10.1177/1062860617732635

M3 - Article

VL - 33

SP - 313

EP - 320

JO - American Journal of Medical Quality

JF - American Journal of Medical Quality

SN - 1062-8606

IS - 3

ER -